Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase.
about
Role of Retinoic Acid-Metabolizing Cytochrome P450s, CYP26, in Inflammation and CancerIdentification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1Lineage-specific duplication of amphioxus retinoic acid degrading enzymes (CYP26) resulted in sub-functionalization of patterning and homeostatic rolesTherapeutic potential of the inhibition of the retinoic acid hydroxylases CYP26A1 and CYP26B1 by xenobiotics.Transcriptome analysis of duck liver and identification of differentially expressed transcripts in response to duck hepatitis A virus genotype C infectionInduction of CYP26A1 by metabolites of retinoic acid: evidence that CYP26A1 is an important enzyme in the elimination of active retinoidsComparison of the function and expression of CYP26A1 and CYP26B1, the two retinoic acid hydroxylasesStereoselective formation and metabolism of 4-hydroxy-retinoic Acid enantiomers by cytochrome p450 enzymes.Hepatic Cyp2d and Cyp26a1 mRNAs and activities are increased during mouse pregnancy.Development and Characterization of Novel and Selective Inhibitors of Cytochrome P450 CYP26A1, the Human Liver Retinoic Acid Hydroxylase.Improved Homology Model of the Human all-trans Retinoic Acid Metabolizing Enzyme CYP26A1.Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions.Comparison of the ligand binding site of CYP2C8 with CYP26A1 and CYP26B1: a structural basis for the identification of new inhibitors of the retinoic acid hydroxylases.CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins
P2860
Q26800202-7045BCB3-28D5-4F2D-ABD9-7C513356ADA8Q28115020-A8373233-AF42-428B-B1F7-1BB74D46AC33Q28559594-02CAF416-68DD-4D6B-ACAD-6AC43E2CCB5AQ34345596-3C700D30-C272-4433-8DA8-BC775E8BF622Q34907844-778D2BC1-0A27-434B-9004-1B4CFECEC4ECQ35156382-5B4C0E5D-36CF-4815-BDCB-8FFE57A27733Q35589480-E7B3AE2B-8F17-439E-8F2A-199BC7A7F898Q36452010-B26805D4-4508-48FF-B9F7-ED4C26C9AE1BQ36573368-1D492821-6F84-42A6-8E16-57426067586DQ38790863-311001C5-DE5E-4863-A0E5-CFD9C329A703Q39902041-1827BEE1-2A44-40F1-B6AB-5C211EB4756EQ51105253-A6BCC31D-7E56-424C-9491-C040FA382E7BQ51636744-95393209-7AA2-474F-853D-B66FA3CC6F52Q57447553-0CFDC581-50CF-49A2-AC1B-3836B8C9CCF9
P2860
Substrate specificity and ligand interactions of CYP26A1, the human liver retinoic acid hydroxylase.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Substrate specificity and liga ...... ver retinoic acid hydroxylase.
@ast
Substrate specificity and liga ...... ver retinoic acid hydroxylase.
@en
type
label
Substrate specificity and liga ...... ver retinoic acid hydroxylase.
@ast
Substrate specificity and liga ...... ver retinoic acid hydroxylase.
@en
prefLabel
Substrate specificity and liga ...... ver retinoic acid hydroxylase.
@ast
Substrate specificity and liga ...... ver retinoic acid hydroxylase.
@en
P2093
P2860
P356
P1476
Substrate specificity and liga ...... ver retinoic acid hydroxylase.
@en
P2093
Brian Buttrick
Jakob A Shimshoni
Jayne E Thatcher
Nina Isoherranen
Scott A Shaffer
Wendel L Nelson
P2860
P304
P356
10.1124/MOL.111.072413
P577
2011-04-26T00:00:00Z